Company: NIVFW
Filing Date: 2025-10-10
Form Type: F-1/A
Source: 0001213900-25-098135
Chunk: 53

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-10
Form: F-1/A
Chunk 53
---
Ivf’s efforts to grow its business may be costlier than it expects, and NewGenIvf may not be able to increase its revenue enough to offset its increased operating expenses. NewGenIvf may incur significant losses in the future for a number of reasons, including the other risks described herein, and unforeseen expenses, difficulties, complications and delays, and other unknown events. If NewGenIvf is unable to sustain profitability, the value of its business and common stock may significantly decrease. NewGenIvf’s future revenue may not grow at the rates it historically has, or at all. NewGenIvf has experienced growth since its business operations started in 2014. Revenue and NewGenIvf’s client base may not grow at the same rates they historically have, or they may decline in the future. NewGenIvf’s future growth will depend, in part, on its ability to:

| ● | continue to attract new clients and/or maintain existing clients; |

| ● | price its solutions and services effectively so that it is able to attract new clients, expand sales to its existing clients and maintain profitability; |

| ● | provide its clients with client support that meets their needs, including through dedicated PNs; |

| ● | maintain successful collection of applicable receivable balances; |

| ● | retain and maintain relationships with high-quality and respected fertility specialists; |

31

| ● | attract and retain highly qualified personnel to support all clients; and |

| ● | increase awareness of its brand and successfully compete with other competitors. |

NewGenIvf may not successfully accomplish all or any of these objectives, which may affect its future revenue, and which makes it difficult for it to forecast its future results of operations. In addition, if the assumptions that NewGenIvf uses to plan its business are incorrect or change in reaction to changes in its market, it may be difficult for it to maintain profitability. NewGenIvf’s shareholders should not rely on its revenue for any prior quarterly or annual periods as any indication of its future revenue or revenue growth. In addition, NewGenIvf expects to continue to expend substantial financial and other resources on:

| ● | sales and marketing; |

| ● | technology infrastructure, including systems architecture, scalability, availability, performance and security; and |

| ● | general administration, including increased legal and accounting expenses associated with being a public company. |

These investments may not result in increased revenue growth in its business. If NewGenIvf is unable to increase its revenue at a rate